250mg - Gefitinib Tablets

Name: 250mg - Gefitinib Tablets
Brand: NEXT GEN BIOTECH
Price: 900.0 INR
Availability: InStock

Price 900.0 INR/ Strip

Get a Price/Quote

MOQ : 1 Box

250mg - Gefitinib Tablets Specification

Dosage Form
Tablets

Salt Composition
Gefitinib Tablets

Indication
Treatment of EGFR-positive Non-Small Cell Lung Cancer (NSCLC)

Origin
India

Enzyme Types
Other

Feature
Other

Ingredients
Other

Application
Other

Ph Level
N/A

Temperature Needed For Fermentation
25 Celsius (oC)

Physical Color/Texture
Other

Fermentation Smell
Normal Smell

Enzymatic Activity
EGFR Tyrosine Kinase Inhibitor (TKI); inhibits epidermal growth factor receptor activity

Storage Instructions
Store below 25 30 C in a cool, dry place; protect from moisture and light

Shelf Life
24 Months

250mg - Gefitinib Tablets Trade Information

Minimum Order Quantity
1 Box

FOB Port
Delhi

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Boxes Per Month

Delivery Time
5 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
Box

Main Export Market(s)
Asia

Main Domestic Market
All India

Certifications
N/A

About 250mg - Gefitinib Tablets

Geffy 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.